The U.S. cancer treatment facilities market size is calculated at USD 12,229 million in 2024 and is predicted to reach around USD 25,439 million by 2034, expanding at a CAGR of 7.6% from 2025 to 2034.
The U.S. cancer treatment facilities market refers to the production, distribution, and application of cancer treatment facilities which are designated as comprehensive cancer centers that conduct research and provide care to cancer patients. Cancer treatment includes surgery, radiation, medicines, and other therapies. Cancer treatment aims to cure or shrink a cancer or stop it from spreading. There are many cancer treatments exist. You may receive one treatment or a combination of treatments. The most common cancer treatments are chemotherapy, surgery, and radiation. Other options include laser therapy, hormonal therapy, immunotherapy, targeted therapy, and others. Chemotherapy can shrink your cancer or slow down its growth, which may help you live longer and help with your symptoms. Chemotherapy is also known as chemo or anti-cancer medication. For a small number of people with borderline resectable cancer, chemotherapy may shrink the cancer enough to make surgery to remove the cancer possible.
Rising incidences of cancer are driving the growth of the U.S. cancer treatment facilities market. Alcohol, tobacco, and obesity are key factors behind the increasing incidence of cancer, with the air population still a key driver of environmental risk factors. An obvious focus for rising cancer rates is the vicious circle of obesity, highly processed foods, and sedentary lifestyles which are an epidemic in America and growing in many countries. A benefit of cancer treatment is that the cancer is cured or controlled sometimes for many years. The cancer staying the same time, or growing slower for a while, can also be a benefit. If a cure is not possible, treatments are used to help shrink your cancer or slow its growth. Radiation therapy is also used in cancer treatment.
Supportive governmental regulations for cancer treatment driving the growth of the U.S. cancer treatment facilities market. Government and other social institutions can contribute to the control of cancer by creating an environment and culture that is supportive of cancer prevention. Cancer insurance can pay benefits for qualified hospital confinements, possibly even in a charity or government facility. Treatments like chemotherapy and radiation, blood/plasma, and platelet procedures, and medical imaging may also be included depending on the coverage offered. The Social Security Administration (SSA) provides financial assistance to people with many different forms of medical disability. Many types of cancer are included in the SSA’s list of covered disabilities. Positive effects of government regulations on business include ensuring high standards of ethics, quality, and safety and providing a predictable and stable business environment. The benefits of regulatory authorities include ensuring that corporations pay their fair share of taxes, preventing harmful practices, protecting consumers and the environment, and ensuring standardized rules across the board which boost the sense of fairness. The government may help healthcare businesses by providing financial, legal, and other assistance. It can also be a public servant, enacting and enforcing consumer protection, labor safety, and other regulations. A supportive regulatory environment ensures that barriers are minimized, allowing businesses to operate effectively and efficiently.
Artificial intelligence (AI) is helping to enhance the speed, accuracy, and reliability of some cancer screening and detection methods which driving the growth of the U.S. cancer treatment facilities market. The Food and Drug Administration (FDA) has authorized the marketing of AI-powered software to help pathologists identify areas of prostate biopsy images that may contain cancer. Artificial intelligence (AI) could help predict the druggability of cancer drug targets. AI improving cancer diagnostics. It can forecast patient survival across many cancer types and accurately pinpoint features in the tissue that surrounds a tumor that is related to a patient’s response to standard treatments including immunotherapy, radiation, chemotherapy, and surgery. AI tool helps predict responses to cancer drugs. AI algorithms can analyze patient data and identify patterns that contribute to the development of specific diseases. The use of AI technology in screening cancer achieves 89% specificity and 76% sensitivity. AI can assess a patient’s risk of developing specific conditions like cancer, diabetes, or cardiovascular diseases.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
| Stats ID: | 7912 |
| Format: | Databook |
| Published: | February 2025 |
| Price | US$ 1550 |
Immediate Delivery
| Stats ID: | 7912 |
| Format: | Databook |
| Published: | February 2025 |
| Price | US$ 1550 |
Immediate Delivery
Unlock unlimited access to all exclusive market research reports, empowering your business.
Get industry insights at the most affordable plan
Stay ahead of the competition with comprehensive, actionable intelligence at your fingertips!
Learn More
